about
Pattern of statin use in southern italian primary care: can prescription databases be used for monitoring long-term adherence to the treatment?Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug-induced liver injury case-control study in Italy.Hypoglycemia, polycythemia and hyponatremia in a newborn exposed to nebivolol during pregnancy.Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011.Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis.Metabolic syndrome and postmenopausal breast cancer: systematic review and meta-analysis.Rational use of antibiotics for the management of children's respiratory tract infections in the ambulatory setting: an evidence-based consensus by the Italian Society of Preventive and Social Pediatrics.DPP-4 inhibitors: pharmacological differences and their clinical implications.The importance of Pharmacovigilance for the drug safety: Focus on cardiovascular profile of incretin-based therapy.Dipeptidyl Peptidase (DPP)-4 Inhibitor-Induced Arthritis/Arthralgia: A Review of Clinical Cases.New era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs).No substantial gender differences in suspected adverse reactions to ACE inhibitors and ARBs: results from spontaneous reporting system in Campania Region.Second generation antipsychotics in 'real-life' paediatric patients. Adverse drug reactions and clinical outcomes of drug switch.Vaccine effectiveness against severe laboratory-confirmed influenza in children: results of two consecutive seasons in Italy.Persistence in Therapy With Risperidone and Aripiprazole in Pediatric Outpatients: A 2-Year Naturalistic Comparison.Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settings.Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs.Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions.Risk of gastrointestinal complications associated to NSAIDs, low-dose aspirin and their combinations: Results of a pharmacovigilance reporting system.Trends in the prescription of antidiabetic medications from 2009 to 2012 in a general practice of Southern Italy: a population-based study.Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling.Complete resistance after maximal dose of rocuronium.Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of Italy.Predictors of mortality in atypical antipsychotic-treated community-dwelling elderly patients with behavioural and psychological symptoms of dementia: a prospective population-based cohort study from Italy.Vitamin D deficiency in type 2 diabetic patients with hypogonadism.Bisphosphonate-related osteonecrosis of the jaw: an Italian post-marketing surveillance analysis.Safety of attention-deficit/hyperactivity disorder medications in children: an intensive pharmacosurveillance monitoring study.Atomoxetine in the treatment of attention deficit hyperactivity disorder and suicidal ideation.Survival from coma induced by an intentional 36-g overdose of extended-release quetiapine.Effects of chronic administration of β-blockers on airway responsiveness in a murine model of heart failure.Disclosing negative trial results – procedure
P50
Q28541300-A040C950-4410-46AD-B531-92A35AEFFC20Q31060620-953A47E9-8824-4444-8CF5-62468C9D94EEQ35056331-408EFFFD-DFF4-42D8-A8B4-B5F1424A6D31Q35684841-AC841108-B5A0-42F3-91F7-25B47E582EB5Q38094977-148DA4FD-C8E2-40A5-9CDF-40CC846D4C54Q38097664-81D54287-FBEF-45BF-B8C6-16C5DCF49679Q38199213-29701E6D-C268-4C5A-B44B-8792CE854466Q38244576-4E4BF768-A4DC-4416-836D-97D298CD551EQ38605987-0B2EC4F8-D0F6-4BD4-86CE-8B5BD6A91C51Q38731788-A7A96FE0-A8F4-4D76-89F6-BA2D83090911Q39016874-F69AB7B4-B2CB-43FD-AD7C-B5DF6976EEFCQ39162849-8E4DD732-F7F8-4006-938B-B3B8C75A65E4Q39162868-008723C0-3551-4419-8140-262392A73A5AQ39170352-2AC9F6B2-B95B-42E7-862B-DAD27AA994BDQ39250552-7364ADC3-D7EE-47B1-8D45-4C74D0C22FFAQ40267262-2E857E94-57C7-41B4-820A-1F4F6BE173BAQ40461980-E36D3CBE-1553-4F5F-B87B-65AFD67C4D33Q40471702-47D4B895-2749-4F7E-B4E0-BBC456CDE9AAQ40842552-035F5F52-AC19-4ABB-9AF3-FC9BB7C82A34Q41428692-AC9787FE-3E1C-48E5-86F8-243B90449A0AQ42114497-B4B849D7-E00A-4923-B8AB-6B579B350CEAQ42718554-60173F61-DE67-47AA-A2B7-E6FF955904EEQ44041568-06D25C96-89F0-4C79-B30A-7342BA038128Q44169182-56C64F66-FF9A-4F05-9B49-13B3ADC6A0F6Q45325095-3CB037A7-A8E9-4136-B580-24C11A2D7ADDQ45786168-76030D7C-6C02-429E-B65F-6E94BEE91409Q46953190-168E67CA-E073-4487-8532-CB47753EFD1CQ48223183-5FE1503C-DAEF-4CA8-86C3-1F0357AFADC1Q48825679-30ABB072-CAF7-4637-A360-1F2DCB245C90Q51727543-AE7AC6D8-0AF7-44F8-AF9C-118976065D39Q61837763-A715263C-9E67-41BC-B027-5D6CA362F525
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Concetta Rafaniello
@ast
Concetta Rafaniello
@en
Concetta Rafaniello
@es
Concetta Rafaniello
@nl
type
label
Concetta Rafaniello
@ast
Concetta Rafaniello
@en
Concetta Rafaniello
@es
Concetta Rafaniello
@nl
prefLabel
Concetta Rafaniello
@ast
Concetta Rafaniello
@en
Concetta Rafaniello
@es
Concetta Rafaniello
@nl
P106
P1153
39561458500
P21
P31
P496
0000-0002-7107-4280